NDC 51759-204

AJOVY

Fremanezumab-vfrm

AJOVY is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Fremanezumab.

Product ID51759-204_08ae1956-25f5-4553-be30-333c558fd801
NDC51759-204
Product TypeHuman Prescription Drug
Proprietary NameAJOVY
Generic NameFremanezumab-vfrm
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2018-09-15
Marketing CategoryBLA / BLA
Application NumberBLA761089
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameFREMANEZUMAB
Active Ingredient Strength225 mg/1.5mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51759-204-10

1 SYRINGE, GLASS in 1 CARTON (51759-204-10) > 1.5 mL in 1 SYRINGE, GLASS
Marketing Start Date2018-09-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51759-204-11 [51759020411]

AJOVY INJECTION
Marketing CategoryBLA
Application NumberBLA761089
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-09-15

NDC 51759-204-10 [51759020410]

AJOVY INJECTION
Marketing CategoryBLA
Application NumberBLA761089
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-09-15

Drug Details

Active Ingredients

IngredientStrength
FREMANEZUMAB225 mg/1.5mL

OpenFDA Data

SPL SET ID:98e344ea-5916-4947-b6f2-4a76ccc04b6b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2056700
  • 2056695
  • Medicade Reported Pricing

    51759020410 AJOVY 225 MG/1.5 ML SYRINGE

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "AJOVY" or generic name "Fremanezumab-vfrm"

    NDCBrand NameGeneric Name
    51759-202AJOVYfremanezumab-vfrm
    51759-204AJOVYfremanezumab-vfrm

    Trademark Results [AJOVY]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    AJOVY
    AJOVY
    87902122 5645449 Live/Registered
    Teva Pharmaceutical Industries Limited
    2018-05-01
    AJOVY
    AJOVY
    87237174 5633449 Live/Registered
    Teva Pharmaceutical Industries Limited
    2016-11-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.